IEQ Capital’s MacroGenics MGNX Stock Holding History

IEQ Capital’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-11,170	Closed	-$14.2K	–	1927
2025 Q1	$14.2K	Buy	+11,170	New	+$29.2K	﹤0.01%	1593

Other funds holding MGNX

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

IEQ Capital's MGNX Position: Q2 2025 in Review

IEQ Capital sold out of MacroGenics (MGNX) in Q2 2025, closing a stake of 11,170 shares — an estimated $14.2K sold.

IEQ Capital first reported a position in MGNX in Q1 2025 and held it in 1 quarter. The position peaked at $14.2K in Q1 2025. 112 funds tracked by Wall St. Rank hold MGNX as of Q2 2025.

IEQ Capital reported no remaining MacroGenics position as of Q2 2025 after selling out during the quarter.
IEQ Capital sold 11,170 MacroGenics shares in Q2 2025, an estimated $14.2K.
IEQ Capital first reported a position in MacroGenics in Q1 2025 and held it in 1 quarter.
IEQ Capital's MacroGenics position peaked at $14.2K in Q1 2025.
112 funds tracked by Wall St. Rank held MacroGenics as of Q2 2025.

Based on IEQ Capital's 13F filing for Q2 2025, filed 14 Aug 2025.